Current Editions
Remembering Sofinnova’s Denis Lucquin, father of French biotech
Investor helped build ecosystem in France and beyond
Management Tracks
Product Development
Psoriasis paves the way for next-generation TYK2 inhibitors in autoimmunity
With positive Phase III data, both Takeda and Alumis are placing broader bets on the TYK2 mechanism
Zentalis leads movers in trio of ovarian cancer updates
BioCentury’s clinical report April 7–14
Management Tracks
Novartis’ Narasimhan joins Anthropic board
BioCentury’s latest roundup of management changes across the biotech industry
BioCentury ISSN 1097-7201